Pediatric non-hodgkin’s lymphoma: Clinical and biologic prognostic factors and risk allocation Sheila WeitzmanKaveri SuryanarayanHoward J. Weinstein OriginalPaper Pages: 107 - 113
Risk assignment in childhood brain tumors: The emerging role of molecular and biologic classification Ian F. PollackJaclyn A. BiegelSydney D. Finkelstein OriginalPaper Pages: 114 - 122
Risk assignment in pediatric soft-tissue sarcomas: An evolving molecular classification Stephen J. QualmanRaffaella A. Morotti OriginalPaper Pages: 123 - 130
Central nervous system-directed therapy in the treatment of childhood acute lymphoblastic leukemia and studies of neurobehavioral outcome: children’s cancer group trials Thomas A. Kaleita OriginalPaper Pages: 131 - 141
The role of radical hysterectomy and neoadjuvant chemotherapy in carcinoma of the cervix David H. Moore OriginalPaper Pages: 145 - 151
Hormone replacement therapy for survivors of breast and endometrial cancer Philip J. DiSaiaWendy R. Brewster OriginalPaper Pages: 152 - 158
Second-line and subsequent therapy for ovarian carcinoma Prema P. PeethambaramHarry J. Long OriginalPaper Pages: 159 - 164
Angiogenesis in ovarian cancer: Molecular pathology and therapeutic strategies Pamela J. Paley OriginalPaper Pages: 165 - 174
Human papillomavirus in cervical cancer F. Xavier BoschSilvia de Sanjosé OriginalPaper Pages: 175 - 184
